Kiniksa Pharmaceuticals is a global biopharmaceutical company that is dedicated to finding and delivering innovative treatments for patients with significant unmet medical needs. Led by a team of distinguished life sciences leaders, Kiniksa is passionate about putting patients at the center of everything they do. With a focus on immune modulation, Kiniksa develops therapies that target unmet needs and underserved conditions, aiming to provide life-changing treatment options.

Kiniksa has a strong pipeline of product candidates at various stages of development and a robust research and development program. They have a history of successful collaborations and partnerships with other organizations to advance their mission. Kiniksa's commitment to integrity and compliance is evident in their unwavering dedication to acting ethically and responsibly in all their endeavors.

With headquarters in the United Kingdom, the United States, and Bermuda, Kiniksa is a global brand that is making a significant impact in the field of biopharmaceuticals. Their focus on patients, their depth of research, and their commitment to developing life-changing medicines are commendable